0 Items
Select Page

Welcome to The Native Antigen Company

World leading infectious disease reagents from the experts

Whether you need cutting-edge reagents for your research or bulk products for manufacturing, we can support your needs

Antigens, Antibodies, Immunoassays

 

We specialise in the development and manufacture of antigens, antibodies and immunoassays for viral and bacterial pathogens. We produce both native and recombinant antigens using our a range of cell expression systems, and have decades of experience in bulk and scale production.

Custom and Contract Research Services

 

We can undertake custom projects to manufacture antigens and other proteins, prepare antibodies and develop immunoassays to support your R&D. Our development laboratories are staffed by a team of PhD molecular biologists and development scientists who are able to execute projects as short as a few days, through to long-term programmes of a year or more.

MXRA8 Receptor

New Antigen and Antibody Conjugation Kits

The Native Antigen Company now offers a range of antigen and antibody conjugation kits that use a novel chemistry to generate highly reproducible protein conjugates.

Zika Immunoassay Kit

SARS-CoV-2 S1 and S2 Antigens Now Available

The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (2019 Novel Coronavirus) in response to urgent demand.

 

Mammalian-Expressed Proteins

African Swine Fever Antigens Now Available

 The Native Antigen Company now offers African Swine Fever Virus antigens for the research and development of diagnostics and vaccines.

About The Native Antigen Company

 The Native Antigen Company specialises in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, as well as bespoke product development and custom manufacturing. The company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system to ensure correct glycosylation and proper folding. The Native Antigen Company’s high-quality reagents are widely adopted by leading pharmaceutical, in vitro diagnostic assay manufacturers, and academic groups in cutting-edge vaccine research and serology, where correct folding and glycosylation are vital.

Novel Coronavirus Antigens Now Available

The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for the 2019 Novel Coronavirus (SARS-CoV-2, Covid-19) in response to urgent demand. These reagents are suitable for use in basic research and the development of diagnostics and...

The Why and How of Protein Conjugation

In this blog, Lead Assay Development Scientist, Toni Ertl discusses the basics of protein conjugation and introduces our new range of conjugation kits for the labelling of antigens and antibodies.Detecting Proteins If you’re trying to detect or measure the presence...

Going Viral: Why We Need New Diagnostics For a Safe and Effective Dengue Vaccine

This article is taken from European Biopharmaceutical Review January 2020, pages 44-46. © Samedan Ltd.The Dengue VirusDengue is the world’s most prevalent and consequential arboviral disease. Current estimates indicate that as many as 390 million dengue infections...

Why We Need New Diagnostics for the Zika Virus

This article has been published in Volume 2, Issue 3 of the IBI journal.While Zika is no longer in the public eye, it hasn’t vanished. Recent outbreaks across Asia and Africa are reminders that Zika is alive and well, and with no effective countermeasures...

Clostridium difficile Toxins: The Nuts and Bolts

In this blog, we describe the mechanisms of action of the Clostridium difficile A and B toxins, and discuss their use in research and medicine. The Native Antigen Company provides biologically active C. diff toxins, as well as inactivated toxoids for a range of...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

15 + 3 =

Live Customer Feedback

Join our mailing list

* indicates required